Medical Xpress

Study finds more comfortable option for guiding breast cancer surgery

A new study led by researchers at Wake Forest University School of Medicine and Atrium Health Levine Cancer has found that a modern technique for locating breast tumors before surgery, called ...
Business Wire

Lumicell’s LumiSystem™ Featured on Viewpoint with Dennis Quaid for New Episode on Fluorescence-Imaging Guidance During Lumpectomy Surgery

NEWTON, Mass.--(BUSINESS WIRE)--Lumicell, Inc., a privately held company focused on developing innovative fluorescence-guided imaging technologies for cancerous tissue detection during surgery, is ...
Morningstar

New Published Data Shows Breast Cancer Locator System Dramatically Improves Surgeon Ability to Remove Entire Tumor With Negative Margins

Cairn Surgical, Inc., an innovative medical technology firm striving to make breast cancer surgery more precise, announced today that a multicenter study just published in the November issue of the ...
Monthly Prescribing Reference

FDA Approves Drug-Device Combo to Detect Residual Cancer After Lumpectomy

Approval was supported by data from a randomized, intra-patient controlled trial, which included patients with confirmed invasive breast cancer, ductal carcinoma in situ, or both. The Food and Drug ...
MarketWatch

Lumicell Announces U.S. Launch and First Commercial Use of LumiSystem(TM), Pioneering Real-Time Detection of Residual Breast Cancer During Lumpectomy

LumiSystem is the first and only fluorescence-guided imaging technology for breast cancer detection, enabling a more complete resection NEWTON, Mass., Jan. 27, 2025 /PRNewswire/ -- Lumicell, Inc., a ...
Morningstar

Lumicell Announces Collaboration with Learn Look Locate to Empower Breast Cancer Patients through Lumpectomy Education

NEWTON, Mass., Dec. 18, 2025 /PRNewswire/ -- Lumicell, Inc., a leader in developing innovative fluorescence-guided imaging technologies for cancer detection, today announced a new collaboration with ...